CytoSorbents Receives M in Non-Dilutive Debt Financing from Bridge Financial institution and Extends Mortgage Settlement

CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Financial institution and Extends Mortgage Settlement

Non-dilutive debt capital at market favorable phrases strengthens the steadiness sheet and offers extra working capital to fund key scientific and industrial initiatives PRINCETON, N.J., Dec. 29, 2022 /PRNewswire/ — CytoSorbents Company (NASDAQ: CTSO), a frontrunner within the therapy of life-threatening circumstances within the intensive care unit and cardiac surgical procedure utilizing blood purification through its proprietary […]

Continue Reading
Clearside Biomedical Enters into Non-Dilutive Financing Settlement with HealthCare Royalty Companions for as much as  Million

Clearside Biomedical Enters into Non-Dilutive Financing Settlement with HealthCare Royalty Companions for as much as $65 Million

Clearside Biomedical, Inc. – Transaction Helps Development of CLS-AX Scientific Program – ALPHARETTA, Ga., Aug. 08, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical firm revolutionizing the supply of therapies to the again of the attention by means of the suprachoroidal house (SCS®), introduced as we speak it has entered right into a […]

Continue Reading